{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:08:35Z","timestamp":1771002515435,"version":"3.50.1"},"reference-count":152,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/gme.0b013e318177352c","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T08:14:53Z","timestamp":1231402493000},"page":"199-213","source":"Crossref","is-referenced-by-count":23,"title":["HIV, reproductive aging, and health implications in women"],"prefix":"10.1097","volume":"16","author":[{"given":"D\u00e9lio Marques","family":"Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar N.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta F.","family":"Finotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia","family":"Costa-Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aar\u00e3o M.","family":"Pinto-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-31-20210227","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/17290376.2005.9724857","article-title":"Women in Chinsapo, Malawi: vulnerability and risk to HIV\/AIDS.","volume":"2","author":"Ghosh","year":"2005","journal-title":"SAHARA J"},{"key":"R3-31-20210227","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/07399330701465010","article-title":"Women and HIV\/AIDS in China: gender and vulnerability.","volume":"28","author":"Lin","year":"2007","journal-title":"Health Care Women Int"},{"key":"R4-31-20210227","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0898264307301173","article-title":"Predictors of condom use and HIV testing among midlife and older women seeking medical services.","volume":"19","author":"Sormanti","year":"2007","journal-title":"J Aging Health"},{"issue":"Suppl 4","key":"R7-31-20210227","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.aids.0000279704.16804.ae","article-title":"Treatment at scale in Brazil: a physician's perspective.","volume":"21","author":"Schechter","year":"2007","journal-title":"AIDS"},{"key":"R8-31-20210227","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/S1020-49892004000800002","article-title":"Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.","volume":"16","author":"Hacker","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"R9-31-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00042560-200001010-00016","article-title":"Perimenopausal symptomatology among HIV-infected women at least 40 years of age.","volume":"23","author":"Clark","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-31-20210227","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/apc.2005.19.703","article-title":"Age of menopause and menopausal symptoms in HIV-infected women.","volume":"19","author":"Fantry","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R11-31-20210227","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/09513590701253743","article-title":"Menopause symptoms in women infected with HIV: prevalence and associated factors.","volume":"23","author":"Ferreira","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R12-31-20210227","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/497270","article-title":"HIV infection, drug use, and onset of natural menopause.","volume":"41","author":"Schoenbaum","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R14-31-20210227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.GME.0000141981.88782.38","article-title":"Menopause symptoms in HIV-infected and drug-using women.","volume":"12","author":"Miller","year":"2005","journal-title":"Menopause"},{"key":"R15-31-20210227","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/jwh.2005.14.898","article-title":"Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women.","volume":"14","author":"Santoro","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"R16-31-20210227","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/09513590600687603","article-title":"The effects of illicit drug use and HIV infection on sex hormone levels in women.","volume":"22","author":"Cofrancesco","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R17-31-20210227","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/gme.0b013e31802f7369","article-title":"Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.","volume":"14","author":"Santoro","year":"2007","journal-title":"Menopause"},{"key":"R18-31-20210227","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1017\/S1355617702860064","article-title":"Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy.","volume":"8","author":"Richardson","year":"2002","journal-title":"J Int Neuropsychol Soc"},{"key":"R19-31-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00126334-200310010-00005","article-title":"Neurocognitive function in HIV-infected patients with low weight and weight loss.","volume":"34","author":"Dolan","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-31-20210227","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jinf.2002.1109","article-title":"Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.","volume":"46","author":"Teichmann","year":"2003","journal-title":"J Infect"},{"key":"R21-31-20210227","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002030-200402200-00014","article-title":"Reduced bone density in HIV-infected women.","volume":"18","author":"Dolan","year":"2004","journal-title":"AIDS"},{"key":"R22-31-20210227","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","article-title":"Bone mass and mineral metabolism in HIV+ postmenopausal women.","volume":"16","author":"Yin","year":"2005","journal-title":"Osteoporos Int"},{"key":"R23-31-20210227","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/501015","article-title":"HIV infection and bone mineral density in middle-aged women.","volume":"42","author":"Arnsten","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R24-31-20210227","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women.","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-31-20210227","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women.","volume":"39","author":"Dolan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-31-20210227","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1468-1293.2006.00401.x","article-title":"Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.","volume":"7","author":"Floris-Moore","year":"2006","journal-title":"HIV Med"},{"key":"R27-31-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.qai.0000220164.72113.12","article-title":"Antiretroviral therapy in HIV-positive women is associated with increased apolipoproteins and total cholesterol.","volume":"42","author":"Rimland","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-31-20210227","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/QAI.0b013e318042d5fe","article-title":"Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.","volume":"45","author":"Anastos","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-31-20210227","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00126334-200303010-00009","article-title":"Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.","volume":"32","author":"Justman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-31-20210227","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/429824","article-title":"Disorders of glucose metabolism among HIV-infected women.","volume":"40","author":"Howard","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R31-31-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.qai.0000147659.80642.5a","article-title":"Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women.","volume":"39","author":"Danoff","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-31-20210227","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"R35-31-20210227","first-page":"169","article-title":"Epidemiology of HIV\/AIDS in Chile. December 2003.","volume":"22","year":"2005","journal-title":"Rev Chilena Infectol"},{"key":"R36-31-20210227","first-page":"589","article-title":"Epidemiology of HIV\/AIDS-United States, 1981-2005.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R38-31-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/07399339709516289","article-title":"AIDS-related risk behaviors and safer sex practices of women in midlife and older in the United States: 1990 to 1992.","volume":"18","author":"Binson","year":"1997","journal-title":"Health Care Women Int"},{"key":"R39-31-20210227","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/0164027598206002","article-title":"Middle-aged and older people with AIDS: trends in national surveillance rates, transmission routes, and risk factors.","volume":"20","author":"Ory","year":"1998","journal-title":"Res Aging"},{"key":"R40-31-20210227","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1089\/jwh.2006.0028","article-title":"Factors associated with lack of interest in HIV testing in older at-risk women.","volume":"16","author":"Akers","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"R41-31-20210227","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1532-5415.2004.52421.x","article-title":"Older women and HIV: how much do they know and where are they getting their information?","volume":"52","author":"Henderson","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R42-31-20210227","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ypmed.2004.03.005","article-title":"The changing age of HIV: sexual risk among older African American women living in rural communities.","volume":"39","author":"Winningham","year":"2004","journal-title":"Prev Med"},{"key":"R43-31-20210227","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/fampra\/cmg612","article-title":"Barriers to seeking treatment for sexual problems in primary care: a qualitative study with older people.","volume":"20","author":"Gott","year":"2003","journal-title":"Fam Pract"},{"key":"R44-31-20210227","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/jwh.2006.15.90","article-title":"Effect of relationship factors on safer sex decisions in older inner-city women.","volume":"15","author":"Paranjape","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"R45-31-20210227","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/aje\/153.9.865","article-title":"Factors associated with age at natural menopause in a multiethnic sample of midlife women.","volume":"153","author":"Gold","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R46-31-20210227","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/kwi324","article-title":"Age at natural menopause and cause-specific mortality.","volume":"162","author":"Mondul","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R47-31-20210227","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.maturitas.2006.09.003","article-title":"Progetto Menopause Italia Study Group. Determinants of age at menopause in women attending menopause clinics in Italy.","volume":"56","author":"Parazzini","year":"2007","journal-title":"Maturitas"},{"key":"R48-31-20210227","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.gme.0000227338.73738.2d","article-title":"Age at menopause in Latin America.","volume":"13","author":"Castelo-Branco","year":"2006","journal-title":"Menopause"},{"key":"R49-31-20210227","first-page":"1875","article-title":"Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause.","volume":"83","author":"Snieder","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-31-20210227","first-page":"17","article-title":"Age at natural menopause among Brazilian women: results from a population-based survey.","volume":"19","author":"Pedro","year":"2003","journal-title":"Cad Saude Publica"},{"key":"R51-31-20210227","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/gme.0b013e318032b2e6","article-title":"Age at natural menopause in Yazd, Islamic Republic of Iran.","volume":"14","author":"Fallahzadeh","year":"2007","journal-title":"Menopause"},{"key":"R52-31-20210227","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.AOG.0000245442.29969.5c","article-title":"Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction.","volume":"108","author":"Cejtin","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R53-31-20210227","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0015-0282(01)02909-0","article-title":"Executive summary: Stages of Reproductive Aging Workshop (STRAW).","volume":"76","author":"Soules","year":"2001","journal-title":"Fertil Steril"},{"key":"R54-31-20210227","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00198-003-1408-1","article-title":"Early menopause: increased fracture risk at older age.","volume":"14","author":"van Der Voort","year":"2003","journal-title":"Osteoporos Int"},{"key":"R55-31-20210227","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1359\/JBMR.040215","article-title":"Risk factors for incident vertebral fractures in men and women: the Rotterdam Study.","volume":"19","author":"van der Klift","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R56-31-20210227","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archinte.159.10.1061","article-title":"Age at natural menopause and risk of cardiovascular disease.","volume":"159","author":"Hu","year":"1999","journal-title":"Arch Intern Med"},{"key":"R57-31-20210227","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.ede.0000165392.35273.d4","article-title":"Age at menopause, cause-specific mortality and total life expectancy.","volume":"16","author":"Ossewaarde","year":"2005","journal-title":"Epidemiology"},{"key":"R58-31-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"R59-31-20210227","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09513590701806870","article-title":"Age at menopause of HIV-infected women: a review.","volume":"24","author":"Conde","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R60-31-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09513590600890306","article-title":"Factors associated with quality of life in a cohort of postmenopausal women.","volume":"22","author":"Conde","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R61-31-20210227","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/aje\/152.5.463","article-title":"Relation of demographic and lifestyle factors to symptoms in a multi-racial\/ethnic population of women 40-55 years of age.","volume":"152","author":"Gold","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R62-31-20210227","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1022074602928","article-title":"Quality of life and menopausal transition for middle-aged women on Kinmen Island.","volume":"12","author":"Fuh","year":"2003","journal-title":"Qual Life Res"},{"key":"R63-31-20210227","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climacteric scale.","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"key":"R64-31-20210227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri-and postmenopausal women: March 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R65-31-20210227","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/j.1326-5377.2007.tb00839.x","article-title":"Ten years of highly active antiretroviral therapy for HIV infection.","volume":"186","author":"Chen","year":"2007","journal-title":"Med J Aust"},{"key":"R66-31-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17425255.3.4.583","article-title":"The role of cytochrome P450 in antiretroviral drug interactions.","volume":"3","author":"Walubo","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R67-31-20210227","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"R68-31-20210227","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.gme.0000196595.82452.ca","article-title":"Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.","volume":"13","author":"Gordon","year":"2006","journal-title":"Menopause"},{"key":"R69-31-20210227","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"R70-31-20210227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R71-31-20210227","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"R72-31-20210227","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"R73-31-20210227","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"R74-31-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00024677-200605020-00002","article-title":"Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.","volume":"5","author":"Stearns","year":"2006","journal-title":"Treat Endocrinol"},{"key":"R75-31-20210227","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/humrep\/15.3.549","article-title":"Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women.","volume":"15","author":"Muttukrishna","year":"2000","journal-title":"Hum Reprod"},{"key":"R76-31-20210227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition.","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"R77-31-20210227","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/dmm020","article-title":"A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project.","volume":"13","author":"Burger","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R78-31-20210227","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2002-020777","article-title":"Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.","volume":"88","author":"Randolph","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R79-31-20210227","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2003-031183","article-title":"Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.","volume":"89","author":"Randolph","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R80-31-20210227","first-page":"967","article-title":"Women's cognitive and affective health and neuropsychiatry.","volume":"73","author":"Aloysi","year":"2006","journal-title":"Mt Sinai J Med"},{"key":"R81-31-20210227","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.maturitas.2006.06.007","article-title":"Cognitive function in late versus early postmenopausal stage.","volume":"56","author":"Elsabagh","year":"2007","journal-title":"Maturitas"},{"key":"R82-31-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.2006.01500.x","article-title":"Oestrogen, cognition and the maturing female brain.","volume":"19","author":"Craig","year":"2007","journal-title":"J Neuroendocrinol"},{"key":"R83-31-20210227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humupd\/dml042","article-title":"Estrogen, cognition and female ageing.","volume":"13","author":"Genazzani","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R85-31-20210227","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13550280390194109","article-title":"Human immunodeficiency virus-associated dementia: an evolving disease.","volume":"9","author":"McArthur","year":"2003","journal-title":"J Neurovirol"},{"key":"R86-31-20210227","first-page":"474","article-title":"Influence of factors not related with HIV infection on neuropsychological performance of HIV-seropositive patients.","volume":"35","author":"Vazquez-Justo","year":"2002","journal-title":"Rev Neurol"},{"key":"R87-31-20210227","first-page":"781","article-title":"Dementia associated with AIDS.","volume":"34","author":"Casanova-Sotolongo","year":"2002","journal-title":"Rev Neurol"},{"key":"R88-31-20210227","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1176\/appi.ajp.159.5.789","article-title":"Depressive and anxiety disorders in women with HIV infection.","volume":"159","author":"Morrison","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R89-31-20210227","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00042560-200208010-00005","article-title":"Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women.","volume":"30","author":"Cook","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R90-31-20210227","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/00002030-199912030-00018","article-title":"Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America.","volume":"13","author":"Moore","year":"1999","journal-title":"AIDS"},{"key":"R91-31-20210227","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S1516-44462006000100004","article-title":"Depression in women infected with HIV.","volume":"28","author":"Mello","year":"2006","journal-title":"Rev Bras Psiquiatr"},{"key":"R92-31-20210227","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.285.11.1466","article-title":"Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.","volume":"285","author":"Ickovics","year":"2001","journal-title":"JAMA"},{"key":"R93-31-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.acn.2006.12.006","article-title":"Grant I; HIV Neurobehavioral Research Center (HNRC) Group. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV.","volume":"22","author":"Woods","year":"2007","journal-title":"Arch Clin Neuropsychol"},{"key":"R94-31-20210227","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1176\/jnp.12.4.451","article-title":"Relationships among apathy, depression, and cognitive impairment in HIV\/AIDS.","volume":"12","author":"Rabkin","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R95-31-20210227","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.psy.45.5.394","article-title":"Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.","volume":"45","author":"Ammassari","year":"2004","journal-title":"Psychosomatics"},{"key":"R96-31-20210227","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-0447.2002.02289.x","article-title":"Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV\/AIDS. The NeuroICONA study.","volume":"106","author":"Starace","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"R97-31-20210227","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneur.59.5.812","article-title":"Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.","volume":"59","author":"De Ronchi","year":"2002","journal-title":"Arch Neurol"},{"key":"R98-31-20210227","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","article-title":"Neurological complications of HIV infection.","volume":"4","author":"McArthur","year":"2005","journal-title":"Lancet Neurol"},{"key":"R99-31-20210227","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archneur.61.11.1687","article-title":"Attenuated central nervous system infection in advanced HIV\/AIDS with combination antiretroviral therapy.","volume":"61","author":"McArthur","year":"2004","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"R100-31-20210227","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00002030-200418001-00012","article-title":"Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.","volume":"18","author":"Valcour","year":"2004","journal-title":"AIDS"},{"key":"R101-31-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease.","volume":"157","author":"McArthur","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R102-31-20210227","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/503565","article-title":"HIV infection and dementia in older adults.","volume":"42","author":"Valcour","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R103-31-20210227","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/00002030-200307040-00015","article-title":"Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.","volume":"17","author":"Dore","year":"2003","journal-title":"AIDS"},{"key":"R104-31-20210227","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era.","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"R105-31-20210227","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e3280ef6acd","article-title":"HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.","volume":"21","author":"McCutchan","year":"2007","journal-title":"AIDS"},{"key":"R106-31-20210227","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1212\/WNL.56.3.415","article-title":"Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes.","volume":"56","author":"Schifitto","year":"2001","journal-title":"Neurology"},{"key":"R107-31-20210227","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy.","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol"},{"key":"R108-31-20210227","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13550280600964576","article-title":"Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.","volume":"12","author":"Wojna","year":"2006","journal-title":"J Neurovirol"},{"key":"R109-31-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0317167100003978","article-title":"HIV-related neurological syndromes reduce health-related quality of life.","volume":"32","author":"Pandya","year":"2005","journal-title":"Can J Neurol Sci"},{"key":"R110-31-20210227","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-200007070-00004","article-title":"Neurocognitive and psychological contributions to quality of life in HIV-1-infected women.","volume":"14","author":"Osowiecki","year":"2000","journal-title":"AIDS"},{"key":"R111-31-20210227","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S1355617704102130","article-title":"The impact of HIV-associated neuropsychological impairment on everyday functioning.","volume":"10","author":"Heaton","year":"2004","journal-title":"J Int Neuropsychol Soc"},{"key":"R112-31-20210227","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002030-200102160-00007","article-title":"Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.","volume":"15","author":"Cohen","year":"2001","journal-title":"AIDS"},{"key":"R113-31-20210227","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4065\/77.7.681","article-title":"Achieving and maintaining cognitive vitality with aging.","volume":"77","author":"Fillit","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R114-31-20210227","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.neubiorev.2006.07.001","article-title":"Differential aging of the brain: patterns, cognitive correlates and modifiers.","volume":"30","author":"Raz","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"R115-31-20210227","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"R116-31-20210227","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.","volume":"286","author":"Siris","year":"2001","journal-title":"JAMA"},{"key":"R117-31-20210227","first-page":"507","article-title":"Prevalence of osteoporosis in postmenopausal women and association with clinical and reproductive factors.","volume":"25","author":"Costa-Paiva","year":"2003","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R118-31-20210227","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00198-003-1458-4","article-title":"Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study.","volume":"14","author":"Shilbayeh","year":"2003","journal-title":"Osteoporos Int"},{"key":"R119-31-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00198-003-1509-x","article-title":"Osteoporosis: prevalence in Taiwanese women.","volume":"15","author":"Yang","year":"2004","journal-title":"Osteoporos Int"},{"key":"R120-31-20210227","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2474-6-34","article-title":"Bone mineral density, body mass index and cigarette smoking among Iranian women: implications for prevention.","volume":"6","author":"Baheiraei","year":"2005","journal-title":"BMC Musculoskelet Disord"},{"key":"R122-31-20210227","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection.","volume":"42","author":"Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R123-31-20210227","doi-asserted-by":"crossref","first-page":"48251","DOI":"10.1074\/jbc.M304676200","article-title":"HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-\/RANKL cross-talk.","volume":"278","author":"Fakruddin","year":"2003","journal-title":"J Biol Chem"},{"key":"R124-31-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00705-004-0395-7","article-title":"HIV-1 Vpr enhances production of receptor of activated NF-B ligand (RANKL) via potentiation of glucocorticoid receptor activity.","volume":"150","author":"Fakruddin","year":"2005","journal-title":"Arch Virol"},{"key":"R125-31-20210227","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1089\/0889222041217482","article-title":"AZT enhances osteoclastogenesis and bone loss.","volume":"20","author":"Pan","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R127-31-20210227","first-page":"2266","article-title":"3rd, Atkinson EJ, Fallon O'WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.","volume":"83","author":"Khosla","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R128-31-20210227","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"R129-31-20210227","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"R130-31-20210227","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","article-title":"Biological effects of short-term or prolonged administration of 9-2-(phosphonomethoxy)propyladenine (tenofovir) to newborn and infant rhesus macaques.","volume":"48","author":"Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R131-31-20210227","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"R132-31-20210227","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI15797","article-title":"The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.","volume":"114","author":"Wang","year":"2004","journal-title":"J Clin Invest"},{"key":"R134-31-20210227","first-page":"145","article-title":"Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.","volume":"84","author":"Aukrust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R135-31-20210227","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/135965350701200701","article-title":"The association of bone mineral density with HIV infection and antiretroviral treatment in women.","volume":"12","author":"Anastos","year":"2007","journal-title":"Antivir Ther"},{"key":"R136-31-20210227","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000145352.04440.1e","article-title":"Alendronate, vitamin D, and calcium for the treatment of osteopenia\/osteoporosis associated with HIV infection.","volume":"38","author":"Mondy","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R137-31-20210227","first-page":"343","article-title":"Reversal of HIV-1-associated osteoporosis with once-weekly alendronate.","volume":"19","author":"Negredo","year":"2005","journal-title":"AIDS"},{"key":"R138-31-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1310\/MD8V-5DLG-EN3T-BRHX","article-title":"Alendronate reduces bone resorption in HIV-associated osteopenia\/osteoporosis.","volume":"5","author":"Guaraldi","year":"2004","journal-title":"HIV Clin Trials"},{"issue":"2","key":"R139-31-20210227","first-page":"CD005645","article-title":"Interventions for the treatment of decreased bone mineral density associated with HIV infection.","author":"Lin","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R140-31-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/QAD.0b013e3280142191","article-title":"Therapeutic management of bone demineralization in the HIV-infected population.","volume":"21","author":"Negredo","year":"2007","journal-title":"AIDS"},{"key":"R141-31-20210227","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R142-31-20210227","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study.","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"R143-31-20210227","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.med.58.072905.180040","article-title":"Cardiovascular risks of antiretroviral therapies.","volume":"58","author":"Mondy","year":"2007","journal-title":"Annu Rev Med"},{"key":"R145-31-20210227","first-page":"1932","article-title":"Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.","volume":"84","author":"Hadigan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R146-31-20210227","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00126334-200312150-00003","article-title":"Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study.","volume":"34","author":"Tien","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R147-31-20210227","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"R148-31-20210227","first-page":"605","article-title":"Prevalence of lipodystrophy in Thai-HIV infected patients.","volume":"87","author":"Puttawong","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"R149-31-20210227","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).","volume":"21","author":"Dong","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R150-31-20210227","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"R151-31-20210227","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-6405-3-17","article-title":"Body image in women with HIV: a cross-sectional evaluation.","volume":"3","author":"Huang","year":"2006","journal-title":"AIDS Res Ther"},{"key":"R152-31-20210227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-2662.2001.00100.x","article-title":"Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment.","volume":"3","author":"Mauss","year":"2002","journal-title":"HIV Med"},{"key":"R153-31-20210227","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2362.1997.1160662.x","article-title":"Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study.","volume":"27","author":"Poehlman","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"R154-31-20210227","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.","volume":"37","author":"Saves","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R155-31-20210227","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/01.STR.32.5.1104","article-title":"Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women.","volume":"32","author":"Matthews","year":"2001","journal-title":"Stroke"},{"key":"R156-31-20210227","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R157-31-20210227","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction.","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"R159-31-20210227","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","article-title":"Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.","volume":"19","author":"Currier","year":"2005","journal-title":"AIDS"},{"key":"R160-31-20210227","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1210\/jc.2006-1140","article-title":"Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.","volume":"91","author":"Johnsen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R161-31-20210227","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.94.1.61","article-title":"Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index.","volume":"94","author":"Akahoshi","year":"1996","journal-title":"Circulation"},{"key":"R162-31-20210227","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.gme.0000247014.56254.12","article-title":"Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.","volume":"14","author":"Otsuki","year":"2007","journal-title":"Menopause"},{"issue":"Suppl 1","key":"R163-31-20210227","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00126334-200209011-00004","article-title":"Cardiovascular risk associated with HIV therapy.","volume":"31","author":"Currier","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R164-31-20210227","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/eurheartj\/ehm296","article-title":"Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.","volume":"28","author":"Collins","year":"2007","journal-title":"Eur Heart J"},{"key":"R165-31-20210227","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s15010-007-6295-5","article-title":"First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).","volume":"35","author":"Carosi","year":"2007","journal-title":"Infection"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200916010-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:52:42Z","timestamp":1709931162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200916010-00031"}},"subtitle":["a literature review"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318177352c","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}